• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOLTOON MEDICAL, INC. TREO ABDOMINAL STENT-GRAFT SYSTEM; STENT, ENDOVASCULAR GRAFT, AORTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOLTOON MEDICAL, INC. TREO ABDOMINAL STENT-GRAFT SYSTEM; STENT, ENDOVASCULAR GRAFT, AORTIC Back to Search Results
Catalog Number 28-B2-26-080U
Medical Device Problem Code Device Endoleak (4074)
Health Effect - Clinical Codes Aneurysm expansion (4597); Clinical Endoleak (4843)
Date of Event 04/28/2026
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Bolton medical, inc.(d/b/a terumo aortic), herein known as the "company", is submitting this report pursuant to 21 cfr part 803, has made reasonable efforts to obtain complete information, and has provided as much as is available to the company as of the submission date of this report.This report is based on information obtained by the company, which may not have been able to fully investigate or verify prior to the date the report was required by the regulations.Any required fields that are unpopulated are blank because the information is currently unknown, unavailable, or not applicable.This report does not constitute an admission or a conclusion by anyone that the device caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the certain regulations, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event or Problem Description
"additional addendum for aaa-0732 on latest form.Subject tpa-004-004's 4-year follow-up occurred on(b)(6) 2026 with the ct dated (b)(6) 2026 reflecting a continued increase in aneurysm due to a type iib endoleak.The investigator assessed the max diameter of the aneurysm at 81mm, which is a 23mm increase compared to 30-day (58mm) assessment and an 11mm increase compared to the previous 3-year (70mm), making for a 2nd occurrence of >5mm enlargement.The subject reported no symptoms during their follow-up.The subject's last reintervention was in feb 2025, which was before their 3-year in 2025 when the first occurrence >5mm enlargement was noted." patient outcome: "no action taken yet as of 12may2026, however an embolization is planned in the future to correct this.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TREO ABDOMINAL STENT-GRAFT SYSTEM
Common Device Name
STENT, ENDOVASCULAR GRAFT, AORTIC
Manufacturer (Section D)
BOLTOON MEDICAL, INC.
799 international parkway
sunrise FL 33325
Manufacturer Contact
manuel benitez
799 international parkway
sunrise, FL 33325
9548389699
MDR Report Key25367322
Report Number2247858-2026-00095
Device Sequence Number13260554
Product Code MIH
UDI-Device Identifier08435761052357
UDI-Public08435761052357
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
P190015
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2026
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Other
Type of Report Initial
Report Date (Section B) 06/02/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Expiration Date09/30/2022
Device Catalogue Number28-B2-26-080U
Device Lot Number2009160287
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/08/2026
Initial Report FDA Received Date06/02/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured09/30/2020
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age86 YR
Patient SexMale
-
-